Segantii Capital Management LTD Seagen Inc. Transaction History

Segantii Capital Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$191.51 - $216.16 $44.2 Million - $49.9 Million	-231,000 Reduced 35.27%	424,000 $90 Million
Q2 2023 Aug 01, 2023	BUY	$187.64 - $206.25 $123 Million - $135 Million	655,000 New	655,000 $126 Million
Q4 2021 Jan 21, 2022	SELL	$142.57 - $190.86 $2.27 Million - $3.04 Million	-15,941 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$142.45 - $169.82 $2.27 Million - $2.71 Million	15,941 New	15,941 $2.71 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Segantii Capital Management LTD with notifications on news.